Saturday 17 October 2026
Export CL’s income statement to Excel — free account
Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024. In the quarter to June 2026, revenue grew 4.91%, EPS fell 5.43%, free cash flow grew 11.7% and total debt fell 10.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five, operating cash flow growth for three.
94.11
1.44
+1.55%
Follow CL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
280.23% | 469.09% | 342.58% | 251.92% | |
Piotroski F-Score |
5 | 6 | 6 | 6 | |
| 16.95% | 13.17% | 12.56% | 11.90% | ||
ROIC |
31.92% | 29.25% | 28.02% | 27.74% | |
Return on Tangible Assets |
70.83% | 60.64% | 43.77% | 42.47% | |
Average Days of Receivables |
32.82 | 30.00 | 33.16 | 34.03 | |
Free Cash Flow per Share |
4.26 | 4.49 | 4.70 | 4.83 | |
Free Cash Flow |
3,443.00 | 3,634.00 | 3,767.00 | 3,858.00 | |
Capital Expenditures |
(571.00) | (564.00) | (578.00) | (598.00) | |
| Other line items | |||||
Cash ROIC |
31.48% | 37.69% | 38.46% | 39.40% | |
Accounts Receivable Turnover |
11.42 | 12.75 | 11.51 | 11.27 | |
Accounts Payable Turnover |
4.59 | 4.18 | 4.26 | 4.27 | |
Inventory Turnover |
3.86 | 4.05 | 3.94 | 3.87 | |
Average Days of Payables |
85.03 | 93.78 | 92.12 | 92.69 | |
Days of Inventory on Hand |
96.10 | 91.22 | 91.68 | 95.58 | |
Tax Rate |
(0.23) | (0.26) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
38.45% | 38.77% | 38.86% | 39.19% | |
Share Based Compensation of Revenue |
0.77% | 0.76% | 0.83% | 0.85% | |
Interest Coverage |
15.79 | 12.38 | 12.14 | 12.32 | |
Operating CF/Net income |
1.38 | 1.97 | 2.08 | 2.19 | |
Depreciation/Fixed assets |
0.13 | 0.33 | 0.34 | 0.34 | |
Capex/Depreciation |
(0.94) | (0.36) | (0.37) | (0.38) | |
Revenue per Share |
24.88 | 25.20 | 25.92 | 26.33 | |
Operating CF per Share |
4.97 | 5.19 | 5.42 | 5.57 | |
Capex per Share |
(0.71) | (0.70) | (0.72) | (0.75) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates